サマリー

がん治療薬の世界市場 2023-2027
がん治療薬市場は、2022-2027年に1,518億4,000万米ドルの成長が予測され、予測期間中のCAGRは11.99%で加速すると予測されています。当レポートでは、がん治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、世界的ながん罹患率の増加、創薬・開発におけるコスト削減の必要性、がん予防に関する認識を広めるための政府や各種非営利団体によるイニシアチブの高まりによって牽引されています。
Technavioのがん治療薬市場は以下のようにセグメント化されている：
治療法別
- 標的療法
- 免疫療法
- ホルモン療法
- 化学療法
販売チャネル別
- オフライン
- オンライン
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間のがん治療薬市場の成長を牽引する主な要因の一つとして、免疫療法の採用が増加していることを挙げている。また、低侵襲外科手術に対する需要の高まりや、バイオ医薬品産業における投資と開発の増加は、市場の大きな需要につながる。
本レポートでは、がん治療薬市場について以下の分野をカバーしています：
- がん治療薬市場のサイジング
- がん治療薬市場の予測
- がん治療薬市場の業界分析
強固なベンダー分析は、クライアントが市場での地位を向上させるのに役立つよう設計されており、これに沿って本レポートでは、AbbVie Inc、アピコス・ファーマ、Arlak Biotech Pvt.Ltd.、Aspen Pharmacare Holdings Ltd.、Astellas Pharma Inc.、AstraZeneca、Athenex Inc.、Bayer AG、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Johnson and Johnson Services Inc.、Kremedine Health Pvt Ltd.、Merck and Co.Inc.、ノバルティスAG、ファイザーInc.、サノフィ、武田薬品工業Inc.Ltd.、Novartis AG、Pfizer Inc.、Sanofi、武田薬品工業株式会社、Bristol Myers Squibb Co.また、癌治療薬市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/oncology-drugs-market-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、統合、総括することにより、市場の詳細な姿を提示しています。業界の主要な影響者を特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global oncology drugs market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global oncology drugs market 2017 - 2021 ($ billion)
o 4.2 Therapy Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Therapy Segment 2017 - 2021 ($ billion)
o 4.3 Distribution Channel Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Therapy
o 6.1 Market segments
o Exhibit 30: Chart on Therapy - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Therapy - Market share 2022-2027 (%)
o 6.2 Comparison by Therapy
o Exhibit 32: Chart on Comparison by Therapy
o Exhibit 33: Data Table on Comparison by Therapy
o 6.3 Targeted therapy - Market size and forecast 2022-2027
o Exhibit 34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
o 6.4 Immunotherapy and hormonal therapy - Market size and forecast 2022-2027
o Exhibit 38: Chart on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
o 6.5 Chemotherapy - Market size and forecast 2022-2027
o Exhibit 42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Therapy
o Exhibit 46: Market opportunity by Therapy ($ billion)
o Exhibit 47: Data Table on Market opportunity by Therapy ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 48: Chart on Distribution Channel - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Distribution Channel - Market share 2022-2027 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 50: Chart on Comparison by Distribution Channel
o Exhibit 51: Data Table on Comparison by Distribution Channel
o 7.3 Offline - Market size and forecast 2022-2027
o Exhibit 52: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Offline - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
o 7.4 Online - Market size and forecast 2022-2027
o Exhibit 56: Chart on Online - Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Online - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Online - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 60: Market opportunity by Distribution Channel ($ billion)
o Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Japan - Market size and forecast 2022-2027
o Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.10 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.11 UK - Market size and forecast 2022-2027
o Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 111: AbbVie Inc. - Overview
o Exhibit 112: AbbVie Inc. - Product / Service
o Exhibit 113: AbbVie Inc. - Key news
o Exhibit 114: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 115: Amgen Inc. - Overview
o Exhibit 116: Amgen Inc. - Product / Service
o Exhibit 117: Amgen Inc. - Key offerings
o 12.5 Aspen Pharmacare Holdings Ltd
o Exhibit 118: Aspen Pharmacare Holdings Ltd - Overview
o Exhibit 119: Aspen Pharmacare Holdings Ltd - Business segments
o Exhibit 120: Aspen Pharmacare Holdings Ltd - Key offerings
o Exhibit 121: Aspen Pharmacare Holdings Ltd - Segment focus
o 12.6 AstraZeneca
o Exhibit 122: AstraZeneca - Overview
o Exhibit 123: AstraZeneca - Product / Service
o Exhibit 124: AstraZeneca - Key news
o Exhibit 125: AstraZeneca - Key offerings
o 12.7 Athenex Inc.
o Exhibit 126: Athenex Inc. - Overview
o Exhibit 127: Athenex Inc. - Product / Service
o Exhibit 128: Athenex Inc. - Key offerings
o 12.8 Bayer AG
o Exhibit 129: Bayer AG - Overview
o Exhibit 130: Bayer AG - Business segments
o Exhibit 131: Bayer AG - Key news
o Exhibit 132: Bayer AG - Key offerings
o Exhibit 133: Bayer AG - Segment focus
o 12.9 Bristol Myers Squibb Co.
o Exhibit 134: Bristol Myers Squibb Co. - Overview
o Exhibit 135: Bristol Myers Squibb Co. - Product / Service
o Exhibit 136: Bristol Myers Squibb Co. - Key news
o Exhibit 137: Bristol Myers Squibb Co. - Key offerings
o 12.10 Eli Lilly and Co.
o Exhibit 138: Eli Lilly and Co. - Overview
o Exhibit 139: Eli Lilly and Co. - Product / Service
o Exhibit 140: Eli Lilly and Co. - Key news
o Exhibit 141: Eli Lilly and Co. - Key offerings
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 142: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 143: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 144: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 145: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 146: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 GlaxoSmithKline Plc
o Exhibit 147: GlaxoSmithKline Plc - Overview
o Exhibit 148: GlaxoSmithKline Plc - Business segments
o Exhibit 149: GlaxoSmithKline Plc - Key news
o Exhibit 150: GlaxoSmithKline Plc - Key offerings
o Exhibit 151: GlaxoSmithKline Plc - Segment focus
o 12.13 Johnson and Johnson Services Inc.
o Exhibit 152: Johnson and Johnson Services Inc. - Overview
o Exhibit 153: Johnson and Johnson Services Inc. - Business segments
o Exhibit 154: Johnson and Johnson Services Inc. - Key news
o Exhibit 155: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 156: Johnson and Johnson Services Inc. - Segment focus
o 12.14 Novartis AG
o Exhibit 157: Novartis AG - Overview
o Exhibit 158: Novartis AG - Business segments
o Exhibit 159: Novartis AG - Key offerings
o Exhibit 160: Novartis AG - Segment focus
o 12.15 Pfizer Inc.
o Exhibit 161: Pfizer Inc. - Overview
o Exhibit 162: Pfizer Inc. - Product / Service
o Exhibit 163: Pfizer Inc. - Key news
o Exhibit 164: Pfizer Inc. - Key offerings
o 12.16 Sanofi
o Exhibit 165: Sanofi - Overview
o Exhibit 166: Sanofi - Business segments
o Exhibit 167: Sanofi - Key news
o Exhibit 168: Sanofi - Key offerings
o Exhibit 169: Sanofi - Segment focus
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 174: Inclusions checklist
o Exhibit 175: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 176: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 177: Research methodology
o Exhibit 178: Validation techniques employed for market sizing
o Exhibit 179: Information sources
o 13.5 List of abbreviations
o Exhibit 180: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global oncology drugs market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Therapy Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Therapy - Market share 2022-2027 (%)
Exhibits31: Data Table on Therapy - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Therapy
Exhibits33: Data Table on Comparison by Therapy
Exhibits34: Chart on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Targeted therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Immunotherapy and hormonal therapy - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Immunotherapy and hormonal therapy - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Chemotherapy - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by Therapy ($ billion)
Exhibits47: Data Table on Market opportunity by Therapy ($ billion)
Exhibits48: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits60: Market opportunity by Distribution Channel ($ billion)
Exhibits61: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2022 and 2027
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AbbVie Inc. - Overview
Exhibits112: AbbVie Inc. - Product / Service
Exhibits113: AbbVie Inc. - Key news
Exhibits114: AbbVie Inc. - Key offerings
Exhibits115: Amgen Inc. - Overview
Exhibits116: Amgen Inc. - Product / Service
Exhibits117: Amgen Inc. - Key offerings
Exhibits118: Aspen Pharmacare Holdings Ltd - Overview
Exhibits119: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits120: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits121: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits122: AstraZeneca - Overview
Exhibits123: AstraZeneca - Product / Service
Exhibits124: AstraZeneca - Key news
Exhibits125: AstraZeneca - Key offerings
Exhibits126: Athenex Inc. - Overview
Exhibits127: Athenex Inc. - Product / Service
Exhibits128: Athenex Inc. - Key offerings
Exhibits129: Bayer AG - Overview
Exhibits130: Bayer AG - Business segments
Exhibits131: Bayer AG - Key news
Exhibits132: Bayer AG - Key offerings
Exhibits133: Bayer AG - Segment focus
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Eli Lilly and Co. - Overview
Exhibits139: Eli Lilly and Co. - Product / Service
Exhibits140: Eli Lilly and Co. - Key news
Exhibits141: Eli Lilly and Co. - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Overview
Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits144: F. Hoffmann La Roche Ltd. - Key news
Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits147: GlaxoSmithKline Plc - Overview
Exhibits148: GlaxoSmithKline Plc - Business segments
Exhibits149: GlaxoSmithKline Plc - Key news
Exhibits150: GlaxoSmithKline Plc - Key offerings
Exhibits151: GlaxoSmithKline Plc - Segment focus
Exhibits152: Johnson and Johnson Services Inc. - Overview
Exhibits153: Johnson and Johnson Services Inc. - Business segments
Exhibits154: Johnson and Johnson Services Inc. - Key news
Exhibits155: Johnson and Johnson Services Inc. - Key offerings
Exhibits156: Johnson and Johnson Services Inc. - Segment focus
Exhibits157: Novartis AG - Overview
Exhibits158: Novartis AG - Business segments
Exhibits159: Novartis AG - Key offerings
Exhibits160: Novartis AG - Segment focus
Exhibits161: Pfizer Inc. - Overview
Exhibits162: Pfizer Inc. - Product / Service
Exhibits163: Pfizer Inc. - Key news
Exhibits164: Pfizer Inc. - Key offerings
Exhibits165: Sanofi - Overview
Exhibits166: Sanofi - Business segments
Exhibits167: Sanofi - Key news
Exhibits168: Sanofi - Key offerings
Exhibits169: Sanofi - Segment focus
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits174: Inclusions checklist
Exhibits175: Exclusions checklist
Exhibits176: Currency conversion rates for US$
Exhibits177: Research methodology
Exhibits178: Validation techniques employed for market sizing
Exhibits179: Information sources
Exhibits180: List of abbreviations